1. Home
  2. MDXH vs GLAC Comparison

MDXH vs GLAC Comparison

Compare MDXH & GLAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXH
  • GLAC
  • Stock Information
  • Founded
  • MDXH 2003
  • GLAC 2021
  • Country
  • MDXH Belgium
  • GLAC China
  • Employees
  • MDXH N/A
  • GLAC N/A
  • Industry
  • MDXH
  • GLAC
  • Sector
  • MDXH
  • GLAC
  • Exchange
  • MDXH Nasdaq
  • GLAC Nasdaq
  • Market Cap
  • MDXH 100.5M
  • GLAC 94.3M
  • IPO Year
  • MDXH 2021
  • GLAC 2023
  • Fundamental
  • Price
  • MDXH $1.77
  • GLAC $10.60
  • Analyst Decision
  • MDXH Strong Buy
  • GLAC
  • Analyst Count
  • MDXH 2
  • GLAC 0
  • Target Price
  • MDXH $7.00
  • GLAC N/A
  • AVG Volume (30 Days)
  • MDXH 98.8K
  • GLAC 155.0K
  • Earning Date
  • MDXH 11-06-2024
  • GLAC 01-01-0001
  • Dividend Yield
  • MDXH N/A
  • GLAC N/A
  • EPS Growth
  • MDXH N/A
  • GLAC N/A
  • EPS
  • MDXH N/A
  • GLAC N/A
  • Revenue
  • MDXH $84,708,000.00
  • GLAC N/A
  • Revenue This Year
  • MDXH $26.39
  • GLAC N/A
  • Revenue Next Year
  • MDXH $18.68
  • GLAC N/A
  • P/E Ratio
  • MDXH N/A
  • GLAC $41.24
  • Revenue Growth
  • MDXH 33.01
  • GLAC N/A
  • 52 Week Low
  • MDXH $0.35
  • GLAC $10.04
  • 52 Week High
  • MDXH $4.64
  • GLAC $10.60
  • Technical
  • Relative Strength Index (RSI)
  • MDXH 26.20
  • GLAC N/A
  • Support Level
  • MDXH $1.62
  • GLAC N/A
  • Resistance Level
  • MDXH $2.24
  • GLAC N/A
  • Average True Range (ATR)
  • MDXH 0.13
  • GLAC 0.00
  • MACD
  • MDXH -0.01
  • GLAC 0.00
  • Stochastic Oscillator
  • MDXH 28.57
  • GLAC 0.00

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.

About GLAC Global Lights Acquisition Corp

Global Lights Acquisition Corp is a blank check company.

Share on Social Networks: